ProCE Banner Activity

Podcast Pearls
TKIs for Advanced HCC in the Second Line and Beyond

Slideset Download
Summary slides for a podcast where Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss the role of tyrosine kinase inhibitors in the second-line treatment of patients with advanced hepatocellular carcinoma.

Released: February 22, 2022

Expiration: February 21, 2023

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma